Shalom Jacobovitz
Vermögen: 23 094 $ am 30.06.2026
Vermögen: 23 094 $ am 30.06.2026
Shalom Jacobovitz currently works at CiVi Biopharma, Inc., as Chief Executive Officer & Director from 2018, CiVi Biopharma Holdings, Inc., as Chief Executive Officer & Director, Eicos Sciences, Inc., as Chief Executive Officer, Clene Nanomedicine, Inc., as Director, and Clene, Inc., as Independent Director from 2021.
Mr. Jacobovitz also formerly worked at American College of Cardiology Foundation, as Chief Executive Officer from 2013 to 2018 and Actelion Pharmaceuticals US, Inc., as President from 2003 to 2013.
Mr. Jacobovitz received his undergraduate degree in 1986 from the University of Western Ontario.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CLENE INC 0.03% | 21.05.2026 | 3’752 ( 0.03% ) | 23 094 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CLENE INC. | Direktor/Vorstandsmitglied | 01.05.2021 |
CiVi Biopharma, Inc.
CiVi Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which manufactures novel therapies against cardiovascular and metabolic diseases | Vorstandsvorsitzender | 02.02.2018 |
Clene Nanomedicine, Inc.
Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company which develops clean-surface nontherapeutic medicines | Direktor/Vorstandsmitglied | - |
CiVi Biopharma Holdings, Inc.
CiVi Biopharma Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage research and development biotechnology company | Vorstandsvorsitzender | - |
| Unternehmen | Position | Ende |
|---|---|---|
American College of Cardiology Foundation
American College of Cardiology Foundation Medical/Nursing ServicesHealth Services Provides cardiovascular education services | Vorstandsvorsitzender | 01.02.2018 |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets drugs | Präsident | 01.04.2013 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
University of Western Ontario
University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American College of Cardiology Foundation
American College of Cardiology Foundation Medical/Nursing ServicesHealth Services Provides cardiovascular education services | Health Services |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets drugs | Health Technology |
Clene Nanomedicine, Inc.
Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company which develops clean-surface nontherapeutic medicines | Health Technology |
CiVi Biopharma, Inc.
CiVi Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which manufactures novel therapies against cardiovascular and metabolic diseases | Health Technology |
CiVi Biopharma Holdings, Inc.
CiVi Biopharma Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage research and development biotechnology company | Commercial Services |
Clene, Inc.
Clene, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen